text stringlengths 1 711 |
|---|
costs, we see SG&A as a lever to help drive operating growth in the years ahead as the |
company 1) continues to exercise disciplined cost management with zero-based |
budgeting practices; and 2) works to take out costs over time related to the ~$100M |
incremental costs associated with the separation from JNJ, including exiting transition |
services agreements, primarily over the next two years as well as transition |
manufacturing agreements, which we estimate account for roughly 60% of the |
incremental stand-alone costs. At the same time, we expect KVUE to further support its |
brands through increased advertising spending in the near term following a period of |
This document is being provided for the exclusive use of DAVID WANG at MARLOWE PARTNERS LP. |
28 |
Andrea Teixeira, CFA AC |
(1-212) 622-6735 |
andrea.f.teixeira@jpmorgan.com |
North America Equity Research |
29 May 2023 J P M O R G A N |
being more selective in 2022. |
Specifically, we are modeling for SG&A as a percent of sales to be 42 bps unfavorable |
YOY in 2023, roughly neutral in 2024, and 51 bps favorable in 2025, which would then |
put SG&A as a percent of sales just below 2022 levels. Within SG&A, advertising has |
been a bit lumpy and oscillated between favorable and unfavorable to margins over the |
past three years. Investments increased in 2021 to support top-line growth and key |
brands but were lower in 2022 as the company made more discriminating decisions on |
advertising given the supply disruptions and inflationary cost environment (balancing |
investment with profitability). We see the company stepping up investments in 2023 to |
support the top-line growth, primarily in the Self Care segment. |
Figure 40: KVUE Operating Expense Outlook |
33.2% |
31.7% |
33.6% 33.4% 33.9% 33.9% 33.3% |
2.7% |
2.2% |
2.4% 2.5% |
2.6% 2.6% |
2.6% |
-250 |
-200 |
-150 |
-100 |
-50 |
0 |
50 |
100 |
150 |
200 |
250 |
29% |
30% |
31% |
32% |
33% |
34% |
35% |
36% |
37% |
2019 2020 2021 2022 2023E 2024E 2025E |
SG&A % of Sales R&D % of Sales YOY Favorable/(Unfavorable) bps |
Source: Company reports and J.P. Morgan estimates. |
Figure 41: KVUE Advertising Expense |
8.8% |
8.5% |
9.7% |
9.1% |
9.5% |
9-10% |
-150 |
-100 |
-50 |
0 |
50 |
100 |
7.5% |
8.0% |
8.5% |
9.0% |
9.5% |
10.0% |
10.5% |
2019 2020 2021 2022 2023E Target |
Advertising Expense % of Sales YOY Favorable/(Unfavorable) bps |
Source: Company reports and J.P. Morgan estimates. |
A&P Spend Is Up but Still Trails Most Peers, Yet... |
KVUEs advertising spend of about 9.1% of sales is a bit below close HPC peers like |
CL (11.1%) and PG (9.9%), although as we noted above we expect A&P spending to |
step up 40 bps in 2023E to 9.5%. We note that some of the comparisons vs. peers are not |
apples to apples as some companies account for go-to-market activities (e.g., sampling, |
sales force, etc.) within advertising expense, which makes spend appear elevated. Also, |
we note that marketing productivity has been up, which helps explain the relatively |
higher efficient ratio (lower A&P as a percentage of sales). Historically, the company |
had made efforts to improve SG&A efficiency through organization redesign (reduced |
head count 10% from 2019-2022) and also increasing ROI on media spend by 28% from |
2019-2021. |
Figure 42: Advertising Expense vs. Peers |
CY22 or Last Fiscal* where noted |
0% |
5% |
10% |
15% |
20% |
25% |
30% |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.